Davis's Drug Guide
dordaviprone
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
Genetic Implications:
Pronunciation:
dor-da-vip-rone
Trade Name(s)
- Modeyso
Ther. Class.
Pharm. Class.
temporary class
protease activatorsThere's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Dordaviprone." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. www.drugguide.com/ddo/view/Davis-Drug-Guide/3580179/all/dordaviprone.
Vallerand AHA, Sanoski CAC. Dordaviprone. Davis's Drug Guide. F.A. Davis Company; 2026. https://www.drugguide.com/ddo/view/Davis-Drug-Guide/3580179/all/dordaviprone. Accessed August 26, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Dordaviprone. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://www.drugguide.com/ddo/view/Davis-Drug-Guide/3580179/all/dordaviprone
Vallerand AHA, Sanoski CAC. Dordaviprone [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 August 26]. Available from: https://www.drugguide.com/ddo/view/Davis-Drug-Guide/3580179/all/dordaviprone.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - dordaviprone
ID - 3580179
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://www.drugguide.com/ddo/view/Davis-Drug-Guide/3580179/all/dordaviprone
PB - F.A. Davis Company
ET - 20
DB - Davis's Drug Guide
DP - Unbound Medicine
ER -